Pharmacology, Toxicology and Pharmaceutical Science
Prescription Drug
100%
Therapeutic Drug Monitoring
87%
Toxic Injury
83%
Prevalence
55%
HIV
41%
Diseases
37%
Narcotic Analgesic Agent
35%
Controlled Substance
34%
Naloxone
33%
Benzodiazepine
31%
Morphine
29%
Carisoprodol
27%
Muscle Relaxant Agent
24%
Xylazine
24%
Cohort Study
22%
Oxycodone
22%
Opioid Overdose
16%
Retrospective Study
16%
Tramadol
16%
Carfentanil
16%
Pharmacovigilance
14%
Buprenorphine
14%
Duragesic
13%
Drug Overdose
13%
Antihypertensive Agent
13%
Amphetamine
12%
Hydrocodone
12%
Comorbidity
10%
Antidepressant
9%
Mortality Rate
9%
Observational Study
9%
Fatality
9%
Health Survey
9%
Combination Therapy
9%
Malignant Neoplasm
8%
Opiate
8%
Adverse Event
8%
Pharmacoepidemiology
8%
Safety Case
8%
Antimalarial Agent
8%
Hepatitis C Virus
8%
Gabapentin
8%
Neuroendocrine Tumor
8%
1 benzyl 3 dimethylamino 2 methyl 1 phenylpropylpropionate hydrochloride
8%
Sepsis
8%
Octreotide
8%
Azithromycin
8%
Heart Infarction
8%
Oxymorphone
8%
Accidental Death
8%
Medicine and Dentistry
Prescription Drug Monitoring Program
95%
Human Immunodeficiency Virus
65%
Analeptic
37%
Controlled Substance
37%
Public Health
35%
Substance Abuse
30%
Surveillance System
28%
Prevalence
27%
Medical Examiner
26%
Diseases
25%
Antiretroviral Therapy
24%
Naloxone
24%
Drug Overdose
22%
Language Processing
22%
Electronic Health Record
22%
Time Series Analysis
20%
Program Effectiveness
18%
Buprenorphine
18%
Neonatal Abstinence Syndrome
18%
Health Outcomes
17%
Systematic Review
16%
Xylazine
16%
Retrospective Study
16%
Carfentanil
16%
Sexually Transmitted Disease
16%
Gynecology
14%
Opioid Crisis
14%
Health Care
12%
Social Determinants of Health
12%
Triage
12%
Benzodiazepine Derivative
12%
Primary Health Care
11%
Pregnant Woman
11%
Primary Prevention
10%
Drug Use
10%
Health Care Cost
10%
Antidepressant
9%
Mental Health
9%
False Positive Result
9%
Electronic Patient Record
9%
Sedative Agent
9%
Emergency Department
8%
Outpatient
8%
Child Health
8%
Patient Care
8%
Hepatitis C Virus
8%
Sepsis
8%
English (Language)
8%
Precursor
8%
Azithromycin
8%
Nursing and Health Professions
Prescription Drug Monitoring Program
49%
Human Immunodeficiency Virus
23%
COVID-19
21%
Logistic Regression Analysis
19%
Central Stimulant Agent
18%
Public Health
18%
HIV Test
16%
Systematic Review
16%
Drug Use
16%
Prevalence
16%
Obstetrician
12%
Gynecologist
12%
Odds Ratio
10%
Health Care Personnel
10%
Prescription Drug
9%
Health Care
9%
Confidence Interval
9%
Doctor Shopping
8%
Lufenuron
8%
Follow up
8%
Antiretroviral Therapy
8%
Drug Overdose
8%
Hepatitis C
8%
Oxycodone
8%
Adolescent
8%
Sepsis
8%
Buprenorphine
8%
Medicare
8%
Epidemiologist
8%
Doctor of Philosophy
8%
Health Survey
8%
Health Outcomes
8%
Electronic Health Record
8%
Benzodiazepine
8%
Vulnerable Population
8%
Health Care Policy
8%
Study Participant
8%
Carfentanil
8%
Sexually Transmitted Disease
8%
Medical Examiner
6%
Diseases
6%
Time Series Analysis
5%
